Dr. Von Roenn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
# Galter
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-6189
Education & Training
- Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
- Rush University Medical CenterResidency, Internal Medicine, 1980 - 1983
- Rush Medical College of Rush University Medical CenterClass of 1980
Certifications & Licensure
- IL State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 37 citationsA Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).Deepa Rao, Zeeshan Butt, Sarah Rosenbloom, Don Robinson, Jamie H. Von Roenn
Journal of Pain and Symptom Management. 2009-08-01 - 278 citationsRandomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.Parkash S. Gill, J C Wernz, David T. Scadden, P Cohen, G M Mukwaya
Journal of Clinical Oncology. 1996-08-01 - 53 citationsPhase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)Virginia G. Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Kalliopi P. Siziopikou, Kirsten Timms
Breast Cancer Research and Treatment. 2015-05-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: